PLK
PLK (Polo-like Kinase) inhibitors target PLKs, a family of serine/threonine kinases that are essential for various stages of cell division, including mitotic entry, spindle assembly, and cytokinesis. PLKs are critical for the proper execution of the cell cycle, and their dysregulation is often associated with cancer. Inhibiting PLKs can induce cell cycle arrest and apoptosis in cancer cells, making these inhibitors important tools in cancer research and therapy. At CymitQuimica, we offer a range of high-quality PLK inhibitors to support your research in mitosis, cell cycle control, and oncology.
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Poloxin-2 REF: TM-T25969CAS: 321695-37-8 | 99.59% | 326.00 €~4,563.00 € | Wed 22 Jan 25 | |
T521 REF: TM-T28904CAS: 891020-54-5 | 99.65% | 381.00 €~3,296.00 € | Wed 05 Feb 25 | |
Plogosertib REF: TM-T71399CAS: 1137212-79-3 | 99.15% - 99.85% | 215.00 €~2,633.00 € | Wed 05 Feb 25 |
Poloxin-2
Ref: TM-T25969
1mg | 326.00 € | ||
5mg | 905.00 € | ||
10mg | 1,115.00 € | ||
25mg | 1,478.00 € | ||
50mg | 1,850.00 € | ||
100mg | 2,320.00 € | ||
500mg | 4,563.00 € |
T521
Ref: TM-T28904
1mg | 381.00 € | ||
5mg | 909.00 € | ||
10mg | 1,197.00 € | ||
25mg | 1,810.00 € | ||
50mg | 2,442.00 € | ||
100mg | 3,296.00 € |
Plogosertib
Ref: TM-T71399
1mg | 215.00 € | ||
5mg | 639.00 € | ||
10mg | 928.00 € | ||
25mg | 1,571.00 € | ||
50mg | 2,050.00 € | ||
100mg | 2,633.00 € |